Private company

Vivo Capital IX, LLC

American company, incorporated in Delaware. Summary from the record

Last updated Oct 21, 2026.

Overview

HeadquartersDE¹

See how the biggest companies compare on our leaderboards

Corporate structure

Vivo Capital IX, LLC sits at the top of its group. 13 entities, 4 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Vivo Capital IX, LLC DE
- Essa Pharma (United States) Stake · Houston
- Genetron Holdings Ltd Stake · Beijing, China
- Instil Bio, Inc. Stake · Dover, Delaware, United States
- IO Biotech, Inc. Stake · DE
- IVERIC bio Stake · New York, New York, United States
- KalVista Pharmaceuticals, Inc. Stake · Cambridge, Massachusetts, United States
- Mereo BioPharma Group plc Stake · London, United Kingdom
- SERA PROGNOSTICS, INC. Stake · Salt Lake City, Utah
- Sierra Oncology, Inc. Stake · San Mateo, California
- Sinovac Biotech Stake · St. John’s, Antigua and Barbuda
- Tarsus Pharmaceuticals, Inc. Stake · Irvine, California
- Zafgen (United States) Stake · Boston, Massachusetts, United States

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (12 companies). Each entity in the chart links to its source.

Stakes it holds

Vivo Capital IX, LLC has told the SEC it owns more than 5% of 12 companies, latest first (Schedules 13D and 13G).

IO Biotech, Inc.SCHEDULE 13G/A Nov 12, 2021 to Nov 14, 2025²
Instil Bio, Inc.SCHEDULE 13G/A Nov 14, 2024 to Aug 12, 2025³
SERA PROGNOSTICS, INC.SCHEDULE 13G/A Feb 13, 2024 to May 15, 2025⁴
Sinovac BiotechSCHEDULE 13D/A Mar 19, 2025⁵
Genetron Holdings LtdSC 13D/A Oct 19, 2023 to Apr 2, 2024⁶
Tarsus Pharmaceuticals, Inc.SC 13G/A Feb 11, 2022 to Feb 13, 2024⁷
IVERIC bioSC 13G/A Feb 11, 2022 to Feb 14, 2023⁸
KalVista Pharmaceuticals, Inc.SC 13G/A Feb 14, 2023⁹
Mereo BioPharma Group plcSC 13G/A Feb 11, 2022 to Feb 14, 2023¹⁰
Sierra Oncology, Inc.SC 13G/A Nov 5, 2021 to Jul 5, 2022¹¹
Essa Pharma (United States)SC 13G/A Feb 11, 2022¹²
Zafgen (United States)SC 13G/A Feb 11, 2022¹³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARVivo Capital IX, LLC filings on SEC EDGAR
2
SEC EDGARVivo Capital IX, LLC SCHEDULE 13G/A on IO Biotech, Inc.
3
SEC EDGARVivo Capital IX, LLC SCHEDULE 13G/A on Instil Bio, Inc.
4
SEC EDGARVivo Capital IX, LLC SCHEDULE 13G/A on SERA PROGNOSTICS, INC.
5
SEC EDGARVivo Capital IX, LLC SCHEDULE 13D/A on Sinovac Biotech
6
SEC EDGARVivo Capital IX, LLC SC 13D/A on Genetron Holdings Ltd
7
SEC EDGARVivo Capital IX, LLC SC 13G/A on Tarsus Pharmaceuticals, Inc.
8
SEC EDGARVivo Capital IX, LLC SC 13G/A on IVERIC bio
9
SEC EDGARVivo Capital IX, LLC SC 13G/A on KalVista Pharmaceuticals, Inc.
10
SEC EDGARVivo Capital IX, LLC SC 13G/A on Mereo BioPharma Group plc
11
SEC EDGARVivo Capital IX, LLC SC 13G/A on Sierra Oncology, Inc.
12
SEC EDGARVivo Capital IX, LLC SC 13G/A on Essa Pharma (United States)
13
SEC EDGARVivo Capital IX, LLC SC 13G/A on Zafgen (United States)